Manufacturing CAR-NK against tumors: Who is the ideal supplier?

Feifei Guo, Yi Zhang, Jiuwei Cui

2024, 36(1): 1-16. doi: 10.21147/j.issn.1000-9604.2024.01.01

Microbiota in colorectal cancer related to liver metastasis

Peijun Wei, Weiming Han, Zitong Zhang, Xue Tian, Chen Yang, Qiaoxuan Wang, Weihao Xie, Ying Liu, Yuanhong Gao, Hui Chang

2024, 36(1): 17-24. doi: 10.21147/j.issn.1000-9604.2024.01.02

Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer

Zhuanzhuan Mu, Xin Zhang, Dongquan Liang, Jugao Fang, Ge Chen, Wenting Guo, Di Sun, Yuqing Sun, Zhentian Kai, Lisha Huang, Jun Liang, Yansong Lin

2024, 36(1): 25-35. doi: 10.21147/j.issn.1000-9604.2024.01.03

Plant-based dietary patterns and risk of esophageal cancer: A prospective cohort study spanning 17 years

Xiaorui Zhang, Feifan He, Jiayue Li, Ru Chen, Xinqing Li, Li Li, Fen Liu, Shaoming Wang, Wenqiang Wei

2024, 36(1): 36-45. doi: 10.21147/j.issn.1000-9604.2024.01.04

A phase I study of Hemay022, an irreversible dual EGFR/HER2 tyrosine kinase inhibitor in Chinese patients with HER2-positive advanced breast cancer

Pin Zhang, Lin Wang, Yueying Zhen, Zhihong Wang, Hesheng Zhang, Richard Jones, Binghe Xu

2024, 36(1): 46-54. doi: 10.21147/j.issn.1000-9604.2024.01.05

Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A phase II single-arm study

Yaping Yang, Liang Jin, Yudong Li, Nanyan Rao, Chang Gong, Shunrong Li, Jiannan Wu, Jinghua Zhao, Linxiaoxiao Ding, Fengxia Gan, Jun Zhang, Ruifa Feng, Zhenzhen Liu, Qiang Liu

2024, 36(1): 55-65. doi: 10.21147/j.issn.1000-9604.2024.01.06

Genomic characterization of peritoneal lavage cytology-positive gastric cancer

Zhouqiao Wu, Tingfei Gu, Changxian Xiong, Jinyao Shi, Jingpu Wang, Ting Guo, Xiaofang Xing, Fei Pang, Ning He, Rulin Miao, Fei Shan, Yuan Zhou, Ziyu Li, Jiafu Ji

2024, 36(1): 66-77. doi: 10.21147/j.issn.1000-9604.2024.01.07

Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study

Changsong Qi, Xiaoyi Chong, Ting Zhou, Mingyang Ma, Jifang Gong, Miao Zhang, Jian Li, Jun Xiao, Xiaohui Peng, Zhen Liu, Zonghai Li, Lin Shen, Xiaotian Zhang

2024, 36(1): 78-89. doi: 10.21147/j.issn.1000-9604.2024.01.08

Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas

Jianwei Zhang, Hanxiao Chen, Junli Zhang, Sha Wang, Yanfang Guan, Wenguang Gu, Jie Li, Xiaotian Zhang, Jian Li, Xicheng Wang, Zhihao Lu, Jun Zhou, Zhi Peng, Yu Sun, Yang Shao, Lin Shen, Minglei Zhuo, Ming Lu

2024, 36(1): 90-102. doi: 10.21147/j.issn.1000-9604.2024.01.09